wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34147910-03299B58-06DD-4DCF-8524-37C4FA3920D6
Q34147910-03299B58-06DD-4DCF-8524-37C4FA3920D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34147910-03299B58-06DD-4DCF-8524-37C4FA3920D6
Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.
P2860
Q34147910-03299B58-06DD-4DCF-8524-37C4FA3920D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34147910-03299B58-06DD-4DCF-8524-37C4FA3920D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c5290247ebedc54b0964a9e9d52a4e113b36907e
P2860
Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells.